# Effectiveness of mRNA Covid-19 Vaccines on Cancer Patients:Observational Study. (ANTICOV)

> **NCT04878796** · — · UNKNOWN · sponsor: **Azienda Socio Sanitaria Territoriale di Cremona** · enrollment: 300 (estimated)

## Conditions studied

- Cancer
- Covid-19
- Vaccine Response

## Interventions

- **DIAGNOSTIC_TEST:** Serum collection, adverse events collection

## Key facts

- **NCT ID:** NCT04878796
- **Lead sponsor:** Azienda Socio Sanitaria Territoriale di Cremona
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-24
- **Primary completion:** 2021-10
- **Final completion:** 2022-05
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2021-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04878796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04878796, "Effectiveness of mRNA Covid-19 Vaccines on Cancer Patients:Observational Study. (ANTICOV)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04878796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*